Colonic FDG uptake pattern in subjects receiving oral contrast with no known or suspected colonic disease

Clinical Nuclear Medicine

Volumn 36, Issue 9, 2011, Pages 754-756

  Jadvar, Hossein ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Colon; CT; FDG; metabolism; PET

Indexed keywords

FLUORODEOXYGLUCOSE F 18;

ADOLESCENT; ADULT; AGED; ARTICLE; ASCENDING COLON; CECUM; CLINICAL ARTICLE; CLINICAL ASSESSMENT; COLON; COLON DISEASE; COMPUTER ASSISTED EMISSION TOMOGRAPHY; DESCENDING COLON; FEMALE; HUMAN; MALE; METABOLISM; NEOPLASM; TRANSVERSE COLON;

ADMINISTRATION, ORAL; ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; COLON; CONTRAST MEDIA; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; MALE; MIDDLE AGED; YOUNG ADULT;

EID: 80051776579     PISSN: 03639762     EISSN: 15360229     Source Type: Journal    
DOI: 10.1097/RLU.0b013e31821c9921     Document Type: Article

References (15)

1. Jadvar H, Schambye RB, Segall GM. Effect of atropine and sincalide on the intestinal uptake of F-18 fluorodeoxyglucose. Clin Nucl Med. 1999;24:965-967.
2. Gollub MJ, Akhurst TJ, Willamson MJ, et al. Feasibility of ex vivo FDG PET of the colon. Radiology. 2009;252:232-239.
3. Tatlidil R, Jadvar H, Bading JR, et al. Incidental colonic fluorodeoxyglucose uptake: correlation with colonoscopic and histopathologic findings. Radiology. 2002;224:783-787. (Pubitemid 34919813)
4. Gutman F, Alberini JL, Wartski M, et al. Incidental colonic focal lesions detected by FDG PET/CT. Am J Roentgenol. 2005;185:495-500.
5. Israel O, Yefremov N, Bar-Shalom R, et al. PET/CT detection of unexpected gastrointestinal foci of 18F-FDG uptake: incidence, localization patterns, and clinical significance. J Nucl Med. 2005;46:758-762.
6. Lee JC, Hartnett GF, Hughes BG, et al. The segmental distribution and clinical significance of colorectal fluorodeoxyglucose uptake incidentally detected on PET-CT. Nucl Med Commun. 2009;30:333-337.
7. Meisner RS, Spier BJ, Einarsson S, et al. Pilot study using PET/CT as a novel, noninvasive assessment of disease activity in inflammatory bowel disease. Inflamm Bowel Dis. 2007;13:993-1000. (Pubitemid 47309971)
8. Ahn BC, Lee SW, Lee J. Intense accumulation of F-18 FDG in colonic wall in adult onset still disease with pseudomembranous colitis. Clin Nucl Med. 2008;33:806-808.
9. Rubin DT, Surma BL, Gavzy SJ, et al. Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission. Inflamm Bowel Dis. 2009;15:750-755.
10. Soyka JD, Strobel K, Veit-Haibach P, et al. Influence of bowel preparation before 18F-FDG PET/CT on physiologic 18F-FDG activity in the intestine. J Nucl Med. 2010;51:507-510.
11. Otsuka H, Kubo A, Graham M, et al. The relationship between standard uptake value (SUV) and Hounsfield unit (HU) of oral contrast agent for FDG PET/CT study. J Med Invest. 2004;51:226-229. (Pubitemid 39610918)
12. Cohade C, Osman M, Nakamoto Y, et al. Initial experience with oral contrast in PET/CT: phantom and clinical studies. J Nucl Med. 2003;44:412-416. (Pubitemid 39586018)
13. Miraldi F, Vesselle H, Faulhaber PF, et al. Elimination of artifactual accumulation of FDG in PET imaging of colorectal cancer. Clin Nucl Med. 1998;23:3-7. (Pubitemid 28069052)
14. Murphy R, Doerger KM, Nathan MA, et al. Pretreatment with diphenoxylate hydrochloride/atropine sulfate (Lomotil) does not decrease physiologic bowel FDG activity on PET/CT scans of the abdomen and pelvis. Mol Imaging Biol. 2009;11:114-117.
15. Gontier E, Fourme E, Wartski M, et al. High and typical 18F-FDG bowel uptake in patients treated with metformin. Eur J Nucl Med Mol Imaging. 2008;35:95-99. (Pubitemid 350234148)